Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BMS completes tender offer for Medarex

This article was originally published in Scrip

Executive Summary

Bristol-Myers Squibb says that it has completed its tender offer for Medarex. The company has tendered around 120 million shares, representing approximately 90.7% of Medarex's outstanding shares. The closing of the tender offer was delayed late last month following an initial struggle to tender shares (, August 21st, 2009). BMS adds that it expects the $2.4 billion deal to be completed imminently.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts